Delivery Order 36F79722D0090-36C26026F0019
Award Date
10/1/25
Potential Completion Date
9/30/26
Potential Value
$111K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Grifols USA LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Mary, FL 32746, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, to the Department of Veterans Affairs (VA). The contract was awarded to Grifols USA LLC, a global healthcare company specializing in the development, manufacturing, and distribution of plasma-derived medicines, transfusion medicine products, and pharmaceutical supplies. The contract is a Delivery Order with a Firm Fixed Price of $120,000.00 and an ultimate...
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols USA LLC, a global healthcare company that specializes in plasma-derived medicines and pharmaceutical supplies. The contract, which is not a set-aside, is for the delivery of PROLASTIN-C, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency, with a ceiling value of $288,931.30 and a completion date of September 30, 2024. Grifols USA LLC holds a Federal...
This federal contract award to Grifols USA LLC, a global healthcare company, is for the pharmaceutical product PROLASTIN-C LIQUID. The contract, valued at $11,502.40, is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). PROLASTIN-C is an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract has a firm fixed price and an ultimate completion date of August 23, 2024. Grifols USA LLC holds a Federal...
This federal contract award is for the delivery of PROLASTIN-C 1000MG VIALS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to Grifols USA LLC, a global healthcare company that specializes in the development, manufacturing, and distribution of plasma-derived medicines and pharmaceutical supplies. The contract is a Delivery Order under Grifols' General Services Administration (GSA) Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and...
The Department of Veterans Affairs Veterans Health Administration awarded a $109,200 delivery order contract to Grifols USA LLC under the company's Pharmaceuticals and Drugs Federal Supply Schedule. The contract calls for Grifols to provide PROLASTIN-C, a drug used to treat alpha-1 antitrypsin deficiency, to facilities located in Los Angeles, California. The base period of performance is one year, from February 8, 2024 through February 7, 2025. Pricing is firm fixed. No subcontractors or...
This federal contract award is to Grifols USA LLC, a global healthcare company, by the Department of Veterans Affairs Veterans Health Administration. The contract is for the delivery of PROLASTIN, a pharmaceutical product, with a potential value of $59,192.70. The contract is a delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is priced on a firm fixed price basis. The contract does not have a set-aside designation. Grifols USA LLC is the prime contractor...
This is a federal contract award for PROLASTIN to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $219,999.96, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 and did not utilize any small business set-asides. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply...
This federal contract award is for the supply of PROLASTIN-C LIQUID, an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The $19,285.20 firm fixed-price purchase order was awarded to Grifols USA LLC, a global healthcare company that specializes in the development, manufacturing, and distribution of plasma-derived medicines, transfusion medicine products, and pharmaceutical supplies. The contract has an ultimate completion date of February 2, 2024 and was awarded on...
This is a federal contract award for the pharmaceutical product Prolastin, awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule, with a firm fixed price and a ceiling value of $162,548.16. This award does not utilize any small business set-asides. Grifols Therapeutics LLC...
This federal contract award is for the drug Prolastin (Prolastin-C, alpha1-proteinase inhibitor) 1000mg/vial injection, with a National Drug Code (NDC) of 13533-0703-10. The contract, worth $193,110.72, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 to Grifols Therapeutics LLC, a for-profit pharmaceutical manufacturer. The contract is a blanket purchase agreement (BPA) call order, with a firm fixed price...